已收盘 10-09 16:00:00 美东时间
+0.280
+0.77%
I can sit through a biotech presentation and come away convinced that the company has discovered the answer to half the problems in modern medicine. The slides look terrific. The market opportunity is enormous. Management seems pretty sure the rest of us will eventually recognize its brilliance. The...
10-08 23:32
今日重点评级关注:Jones Trading:维持Opus Genetics"买入"评级,目标价从10美元升至17美元;Citizens:维持Rezolute"跑赢大市"评级,目标价从11美元升至15美元
10-07 17:30
Xenon Pharmaceuticals Inc. announced equity inducement grants to eight new non-officer employees, including 17,850 share options and 10,500 restricted share units (RSUs), approved by the Compensation Committee. The share options have an exercise price of $38.93 per common share and vest over four years, while RSUs vest annually over four years. Both grants are subject to the 2025 Inducement Equity Incentive Plan. Xenon focuses on developing life-...
10-02 20:01
Xenon Pharmaceuticals shares are trading higher after Form 4 filings indicated that the company's CEO and CFO bought a combined 45,000 shares.
10-02 00:30
中美高层会谈释放积极信号!纳指期货升逾1%;比特币再度站上8.5万美元,小摩称其升势比黄金“更强”;英特尔盘前升逾5%,布局先进封装剑指光通信赛道>>
09-21 20:14
今日重点评级关注:康托·菲茨杰拉德:维持Abeona Therapeutics"超配"评级,目标价从28美元升至30美元;HC Wainwright & Co.:维持Oculis Holding"买入"评级,目标价从26美元升至39美元
09-21 16:25
汇通财经APP讯——周一(北京时间9月21日)亚市早盘,现货黄金交投于4373美元/盎司附近,金价受益于油价走低缓解了市场对通胀压力持续的担忧,日内或再决战...
09-21 07:20
Xenon Pharmaceuticals (XENE) fell 30% to reach its lowest level since November after the company paused enrollment in Phase 3 depression trials for its lead asset, azetukalner, following safety concer...
09-19 01:27
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) submitted a New Drug Application to the U.S. Food and Drug Administration for its investigational drug azetukalner to treat focal seizures. Simultaneously, the neuroscience-focused biopharmaceutical company announced a voluntary pause on new patient enrollmen...
09-18 23:14
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital analyst Tamy Chen downgraded Magna International Inc (NYSE:MGA) from Outperform to Ma...
09-18 20:48